Health economic outcomes of a minimal monitoring approach to providing HCV therapy
MINMON is a cost-saving strategy for HCV treatment, particularly in low- and middle-income country settings.
Authors
- Tannishtha Pramanick
- Benjamin P. Linas (ORCID: https://orcid.org/0000-0001-9574-7075)
- Sunil S. Solomon (ORCID: https://orcid.org/0000-0002-3296-1514)
- Mark Sulkowski (ORCID: https://orcid.org/0000-0002-2145-6352)
- Michelle Weitz
- Laura Smeaton (ORCID: https://orcid.org/0000-0001-7243-4703)
- Sandra Wagner Cardoso (ORCID: https://orcid.org/0000-0001-5230-0003)
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Cancer Research And Biostatistics (US)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1097/hc9.0000000000000579
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00